ZNF77 | Zinc finger protein 77 | Transcription factors
| ![](/images/23397/ihc_selected_60x60.jpg) | ![](/images/23397/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23397/51832_B_8_1_rna_selected_60x60.jpg) | Mixed |
TLE6 | Transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
TLE2 | Transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) | | ![](/images/49103/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49103/114412_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
AES | Amino-terminal enhancer of split | | ![](/images_static/rna_center.gif) | ![](/images/49499/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
GNA11 | Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | Cancer-related genes Disease related genes
| ![](/images/48886/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48886/112924_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
GNA15 | Guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | Plasma proteins
| ![](/images/43113/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43113/96362_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
S1PR4 | Sphingosine-1-phosphate receptor 4 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/60601/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60601/136482_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
NCLN | Nicalin | Predicted membrane proteins
| ![](/images/6625/ihc_selected_60x60.jpg) | ![](/images/6625/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/6625/20050_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CELF5 | CUGBP, Elav-like family member 5 | | | ![](/images_static/na_center.gif) | ![](/images/60336/ihc_cell_selected_60x60.jpg) | ![](/images/60336/135455_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
NFIC | Nuclear factor I/C (CCAAT-binding transcription factor) | Transcription factors
| | | | ![](/images/52625/137996_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
C19orf77 | Chromosome 19 open reading frame 77 | Predicted membrane proteins
| ![](/images/45046/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45046/102113_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DOHH | Deoxyhypusine hydroxylase/monooxygenase | Enzymes
| ![](/images/41953/ihc_selected_60x60.jpg) | ![](/images/41953/if_selected_60x60.jpg) | ![](/images/41953/ihc_cell_selected_60x60.jpg) | ![](/images/41953/91137_B_9_1_rna_selected_60x60.jpg) | Mixed |
FZR1 | Fizzy/cell division cycle 20 related 1 (Drosophila) | | ![](/images/43536/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43536/98030_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MFSD12 | Major facilitator superfamily domain containing 12 | Predicted membrane proteins
| ![](/images/42149/ihc_selected_60x60.jpg) | ![](/images/42149/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42149/90069_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
C19orf71 | Chromosome 19 open reading frame 71 | | ![](/images/48654/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48654/111039_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
HMG20B | High mobility group 20B | Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
GIPC3 | GIPC PDZ domain containing family, member 3 | Disease related genes
| ![](/images/61258/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/61258/140409_B_9_5_rna_selected_60x60.jpg) | Mixed |
TBXA2R | Thromboxane A2 receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CACTIN | Cactin, spliceosome C complex subunit | | | | ![](/images/42548/ihc_cell_selected_60x60.jpg) | ![](/images/42548/92249_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
PIP5K1C | Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | Disease related genes Enzymes Potential drug targets
| ![](/images/17168/ihc_selected_60x60.jpg) | ![](/images/17168/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17168/40153_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
TJP3 | Tight junction protein 3 | | | | ![](/images_static/rna_center.gif) | ![](/images/13244/29827_B_7_5_rna_selected_60x60.jpg) | Mixed |
APBA3 | Amyloid beta (A4) precursor protein-binding, family A, member 3 | | | ![](/images/45577/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45577/101773_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
MRPL54 | Mitochondrial ribosomal protein L54 | Mitochondrial proteins
| ![](/images/46767/ihc_selected_60x60.jpg) | ![](/images/46767/if_selected_60x60.jpg) | ![](/images/42117/ihc_cell_selected_60x60.jpg) | ![](/images/46767/113862_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
RAX2 | Retina and anterior neural fold homeobox 2 | Disease related genes Transcription factors
| ![](/images/52533/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52533/135373_B_7_8_rna_selected_60x60.jpg) | Not detected |
MATK | Megakaryocyte-associated tyrosine kinase | Cancer-related genes Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4847/15762_B_9_3_rna_selected_60x60.jpg) | Mixed |
ZFR2 | Zinc finger RNA binding protein 2 | | ![](/images/55678/ihc_selected_60x60.jpg) | ![](/images/55678/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55678/147251_A_3_5_rna_selected_60x60.jpg) | Group enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images/17755/ihc_cell_selected_60x60.jpg) | ![](/images/17755/52926_A_4_7_rna_selected_60x60.jpg) | Tissue enriched |
NMRK2 | Nicotinamide riboside kinase 2 | Enzymes
| ![](/images/49909/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49909/111896_B_8_2_rna_selected_60x60.jpg) | Group enriched |
DAPK3 | Death-associated protein kinase 3 | Enzymes Predicted membrane proteins
| ![](/images/28569/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/28569/ihc_cell_selected_60x60.jpg) | ![](/images/28569/92156_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
EEF2 | Eukaryotic translation elongation factor 2 | Cancer-related genes Disease related genes Plasma proteins
| ![](/images/7795/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/7795/20894_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
PIAS4 | Protein inhibitor of activated STAT, 4 | | ![](/images/10598/ihc_selected_60x60.jpg) | ![](/images/10598/if_selected_60x60.jpg) | ![](/images/10598/ihc_cell_selected_60x60.jpg) | ![](/images/10598/25734_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
AC016586.1 | | Predicted secreted proteins
| ![](/images/62825/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62825/141421_B_7_8_rna_selected_60x60.jpg) | Not detected |
ZBTB7A | Zinc finger and BTB domain containing 7A | Transcription factors
| | ![](/images/46387/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37285/72642_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | ![](/images/3835/11076_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| ![](/images/40671/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40671/86502_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SIRT6 | Sirtuin 6 | | ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
ANKRD24 | Ankyrin repeat domain 24 | | ![](/images/48498/ihc_selected_60x60.jpg) | ![](/images/41534/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48498/110121_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| ![](/images/46635/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/46635/137478_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
CCDC94 | Coiled-coil domain containing 94 | | ![](/images/43606/ihc_selected_60x60.jpg) | | ![](/images/43606/ihc_cell_selected_60x60.jpg) | ![](/images/43606/101119_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
SHD | Src homology 2 domain containing transforming protein D | | ![](/images/17955/ihc_selected_60x60.jpg) | ![](/images/17955/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17955/40889_B_7_7_rna_selected_60x60.jpg) | Group enriched |
TMIGD2 | Transmembrane and immunoglobulin domain containing 2 | Predicted membrane proteins
| ![](/images/11081/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11081/27595_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
FSD1 | Fibronectin type III and SPRY domain containing 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43141/140602_B_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
STAP2 | Signal transducing adaptor family member 2 | | ![](/images/2375/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2375/10244_B_8_8_rna_selected_60x60.jpg) | Mixed |
MPND | MPN domain containing | Enzymes
| ![](/images/45475/ihc_selected_60x60.jpg) | ![](/images/43274/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45475/114153_B_4_2_rna_selected_60x60.jpg) | Expressed in all |
SH3GL1 | SH3-domain GRB2-like 1 | Cancer-related genes Disease related genes
| ![](/images/21485/ihc_selected_60x60.jpg) | | | ![](/images/21485/49411_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
CHAF1A | Chromatin assembly factor 1, subunit A (p150) | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15186/34354_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
UBXN6 | UBX domain protein 6 | Plasma proteins
| ![](/images/41313/ihc_selected_60x60.jpg) | ![](/images/40906/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40906/89275_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
HDGFRP2 | Hepatoma-derived growth factor-related protein 2 | | | | ![](/images/42559/ihc_cell_selected_60x60.jpg) | ![](/images/44208/109521_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
PLIN4 | Perilipin 4 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/44682/ihc_cell_selected_60x60.jpg) | ![](/images/44682/152672_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PLIN5 | Perilipin 5 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |